You are here

Bioiberica takes part at the CPhl China 2017 fair in Shanghai, China (booth E1Q18)

19 Jun 2017
Bioiberica
  • The CPhl China 2017 fair is the most important pharmaceutical fair on active ingredients in the Asia-Pacific region
  •  Bioiberica is presenting their leading active and branded ingredients, as well as end user products for human healthcare

This week, Bioiberica is participating at one of the most important events in the Asiatic continent: the CPhI China fair. This fair will be attended by more than 40,000 professionals from more than 120 countries, and is being held on 20-22 June 2017 in Shanghai, People’s Republic of China.

At booth E1Q18, Bioiberica’s Heparin Science and Human Health Divisions will present the leading pharmaceutical active ingredients in which our company specializes (heparin, chondroitin sulfate, glucosamine, hyaluronic acid), in addition to branded ingredients and end-user products for joint care.

As highlighted by the organizers, this fair not only helps define business opportunities and establish new partnerships; it is also an educational platform which allows firms to learn about the latest updates in their sector. Experts have forecasted that China will be the fastest growing market for biological products over the next decade, so it doesn’t come as a surprise that, according to the CPhl, 74% of international pharmaceutical or generic-producing firms are striving to “increase or initiate associations with local firms”. 

Bioiberica, a firm with more than 40 years worth of experience in the development and production of biomolecules for the pharmaceutical industry, would like to invite all visitors to visit our booth to learn more about the solutions we can offer. 

Related News

23 Jan 2024
Bioiberica

On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.

16 Oct 2023
Bioiberica

We participated in CPHI 2023 in Barcelona, ​​where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.

4 May 2023
Bioiberica

They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs

Bioiberica